RPE cells

Intravitreal brimonidine holds promise for slowing GA growthBrimonidine Drug Delivery System (Brimo DDS) in an intravitreally administered, sustained-release implant (Allergan) shows promise as a treatment for geographic atrophy (GA), secondary to age-related macular degeneration in a phase IIa clinical trial.
Laser advances take retina specialty to new levels of treatment, careDevelopments in lasers, along with genetic engineering, are showing promise as technologies that may shape the future of retina treatment.
Laser shows promise in limiting AMD progressionA proprietary retinal laser technology has demonstrated the potential to reverse the accumulation of drusen in patients with high-risk early AMD over a 24-month period.